| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 7.44e-12 | 37 | 153 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 9.68e-12 | 38 | 153 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 3.49e-07 | 20 | 153 | 5 | GO:0061608 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.74e-06 | 27 | 153 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 4.22e-06 | 32 | 153 | 5 | GO:0140142 | |
| GeneOntologyMolecularFunction | signal sequence binding | 4.37e-05 | 51 | 153 | 5 | GO:0005048 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 6.96e-05 | 11 | 153 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.04e-04 | 61 | 153 | 5 | GO:0030374 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.51e-04 | 14 | 153 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.80e-04 | 37 | 153 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | molecular carrier activity | 1.85e-04 | 108 | 153 | 6 | GO:0140104 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.21e-04 | 46 | 153 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 5.30e-04 | 21 | 153 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | disaccharide binding | 1.19e-03 | 7 | 153 | 2 | GO:0048030 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.08e-07 | 20 | 154 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | viral penetration into host nucleus | 1.62e-06 | 4 | 154 | 3 | GO:0075732 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 4.04e-06 | 5 | 154 | 3 | GO:0048496 | |
| GeneOntologyBiologicalProcess | negative regulation of mammary gland epithelial cell proliferation | 1.40e-05 | 7 | 154 | 3 | GO:0033600 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 3.95e-05 | 84 | 154 | 6 | GO:0061180 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 SP1 SLC6A19 KPNA6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-19 ERVK-24 NOTCH1 KPNA2 KPNA3 | 4.70e-05 | 464 | 154 | 13 | GO:0016032 |
| GeneOntologyBiologicalProcess | developmental growth | NCOA3 ERBB4 FN1 NLGN4Y NTRK3 UBTFL1 GATA3 ZMIZ1 SIX1 TBL1XR1 BMPR2 NLGN4X SLC12A2 BRCA2 ITSN2 ROBO1 ALCAM MED12 NOTCH1 | 5.08e-05 | 911 | 154 | 19 | GO:0048589 |
| GeneOntologyBiologicalProcess | negative regulation of cell proliferation involved in heart valve morphogenesis | 5.54e-05 | 2 | 154 | 2 | GO:0003252 | |
| GeneOntologyBiologicalProcess | entry of viral genome into host nucleus through nuclear pore complex via importin | 5.54e-05 | 2 | 154 | 2 | GO:0075506 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | KPNA4 KPNA5 ERBB4 KALRN SYNE1 PEX14 KPNA6 TEX15 HUWE1 CUBN SIX1 SPAG5 PTPN5 BRCA2 INTS13 EMC10 SIX2 NOTCH1 PCM1 KPNA2 KPNA3 | 6.34e-05 | 1091 | 154 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | intracellular transport of virus | 6.45e-05 | 11 | 154 | 3 | GO:0075733 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | DNHD1 SP1 BRIP1 SPATA31E1 KALRN NLGN4Y SYNE1 SPATA31C2 KPNA6 RSPH6A TEX15 ZMIZ1 SPATA31C1 FANCA BMPR2 NLGN4X BRCA2 TMF1 PLD6 SPACA5 HERC2 NOTCH1 | 7.95e-05 | 1194 | 154 | 22 | GO:0048609 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 8.62e-05 | 299 | 154 | 10 | GO:0060560 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | KPNA4 KPNA5 SYNE1 KPNA6 SIX1 PTPN5 INTS13 SIX2 NOTCH1 KPNA2 KPNA3 | 8.98e-05 | 362 | 154 | 11 | GO:0034504 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | ERVK-6 SP1 GATAD2A FN1 GATA3 ETS1 ETS2 RNF213 ERVK-21 ERVK-9 SIX1 HPSE BMPR2 DLC1 SLC12A2 PRCP ERVK-8 TMF1 ROBO1 EMC10 ERVK-19 ENPEP SIX2 MED12 NOTCH1 | 1.03e-04 | 1483 | 154 | 25 | GO:0048646 |
| GeneOntologyBiologicalProcess | DNA integration | 1.10e-04 | 13 | 154 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.11e-04 | 195 | 154 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.37e-04 | 201 | 154 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | response to mercury ion | 1.40e-04 | 14 | 154 | 3 | GO:0046689 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.65e-04 | 3 | 154 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | regulation of cell proliferation involved in heart valve morphogenesis | 1.65e-04 | 3 | 154 | 2 | GO:0003250 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in heart valve morphogenesis | 1.65e-04 | 3 | 154 | 2 | GO:0003249 | |
| GeneOntologyBiologicalProcess | promoter clearance during DNA-templated transcription | 1.65e-04 | 3 | 154 | 2 | GO:0001109 | |
| GeneOntologyBiologicalProcess | RNA polymerase II promoter clearance | 1.65e-04 | 3 | 154 | 2 | GO:0001111 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.74e-04 | 15 | 154 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | mammary gland development | 2.19e-04 | 162 | 154 | 7 | GO:0030879 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | NCOA3 SP1 GATAD2A FN1 GATA3 ETS1 RNF213 ZMIZ1 SIX1 HPSE BMPR2 DLC1 SLC12A2 PRCP ROBO1 EMC10 ENPEP SIX2 MED12 NOTCH1 | 2.76e-04 | 1125 | 154 | 20 | GO:0035239 |
| GeneOntologyBiologicalProcess | tube development | NCOA3 SP1 BRIP1 GATAD2A FN1 GATA3 ETS1 RNF213 ZMIZ1 SIX1 HPSE BMPR2 LIPA DLC1 SLC12A2 PRCP ROBO1 EMC10 ENPEP SDC1 SIX2 MED12 NOTCH1 | 2.99e-04 | 1402 | 154 | 23 | GO:0035295 |
| GeneOntologyBiologicalProcess | positive regulation of ureteric bud formation | 3.29e-04 | 4 | 154 | 2 | GO:0072107 | |
| GeneOntologyBiologicalProcess | regulation of ureteric bud formation | 3.29e-04 | 4 | 154 | 2 | GO:0072106 | |
| GeneOntologyBiologicalProcess | negative regulation of cell proliferation involved in heart morphogenesis | 3.29e-04 | 4 | 154 | 2 | GO:2000137 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 3.29e-04 | 4 | 154 | 2 | GO:0043322 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 3.29e-04 | 4 | 154 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in heart valve development | 3.29e-04 | 4 | 154 | 2 | GO:2000793 | |
| GeneOntologyBiologicalProcess | aortic valve development | 3.82e-04 | 46 | 154 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 4.41e-04 | 85 | 154 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 4.41e-04 | 85 | 154 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | SHLD2 IGLV2-33 IGLV2-23 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGHD | 4.67e-04 | 241 | 154 | 8 | GO:0002377 |
| GeneOntologyBiologicalProcess | regulation of cell proliferation involved in heart morphogenesis | 4.92e-04 | 21 | 154 | 3 | GO:2000136 | |
| GeneOntologyBiologicalProcess | regulation of mammary gland epithelial cell proliferation | 4.92e-04 | 21 | 154 | 3 | GO:0033599 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | KPNA4 KPNA5 PEX14 KPNA6 HUWE1 CUBN PTPN5 BRCA2 SIX2 NOTCH1 KPNA2 KPNA3 | 5.01e-04 | 515 | 154 | 12 | GO:0072594 |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 5.27e-04 | 50 | 154 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | syncytium formation | 5.45e-04 | 89 | 154 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | regulation of mesonephros development | 5.46e-04 | 5 | 154 | 2 | GO:0061217 | |
| GeneOntologyBiologicalProcess | nuclear transport | 5.63e-04 | 378 | 154 | 10 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 5.63e-04 | 378 | 154 | 10 | GO:0006913 | |
| GeneOntologyBiologicalProcess | response to nutrient | 6.10e-04 | 192 | 154 | 7 | GO:0007584 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in heart morphogenesis | 6.48e-04 | 23 | 154 | 3 | GO:0061323 | |
| GeneOntologyBiologicalProcess | transport of virus | 7.36e-04 | 24 | 154 | 3 | GO:0046794 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 7.36e-04 | 24 | 154 | 3 | GO:0003177 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 5.48e-09 | 10 | 157 | 5 | GO:0042564 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.70e-08 | 12 | 157 | 5 | GO:0031074 | |
| GeneOntologyCellularComponent | host cell | 3.38e-05 | 9 | 157 | 3 | GO:0043657 | |
| GeneOntologyCellularComponent | host cellular component | 1.77e-04 | 15 | 157 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 2.64e-04 | 166 | 157 | 7 | GO:0019814 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 3.33e-04 | 4 | 157 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | USH2 complex | 3.33e-04 | 4 | 157 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 8.24e-04 | 6 | 157 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 8.24e-04 | 6 | 157 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 8.24e-04 | 6 | 157 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 8.24e-04 | 6 | 157 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | apical plasma membrane | FN1 SLC6A19 CUBN BMPR2 SLC12A2 PTPRH SLC15A1 USH2A MUC4 ENPEP NOTCH1 | 1.16e-03 | 487 | 157 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.52e-03 | 8 | 157 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | cell projection membrane | SLC6A19 ADGRV1 CUBN DLC1 SLC12A2 PTPRH ROBO1 USH2A MUC4 ENPEP | 1.59e-03 | 431 | 157 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | inhibitory synapse | 1.60e-03 | 31 | 157 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | apical part of cell | FN1 SLC6A19 CUBN BMPR2 SLC12A2 PTPRH SLC15A1 USH2A MUC4 ENPEP NOTCH1 PCM1 | 1.75e-03 | 592 | 157 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | inner dynein arm | 2.42e-03 | 10 | 157 | 2 | GO:0036156 | |
| HumanPheno | Renal insufficiency | BRIP1 FN1 GATA3 GATM CUBN SIX1 F5 FANCA LRIG2 BRCA2 SHPK IQCB1 ROBO1 MED12 MOCOS | 8.86e-06 | 421 | 51 | 15 | HP:0000083 |
| Domain | Arm_3 | 4.57e-10 | 7 | 140 | 5 | PF16186 | |
| Domain | Importing_su_alpha | 4.57e-10 | 7 | 140 | 5 | IPR024931 | |
| Domain | IBB | 4.57e-10 | 7 | 140 | 5 | PF01749 | |
| Domain | Arm_3 | 4.57e-10 | 7 | 140 | 5 | IPR032413 | |
| Domain | IBB | 1.21e-09 | 8 | 140 | 5 | PS51214 | |
| Domain | Importin-a_IBB | 2.71e-09 | 9 | 140 | 5 | IPR002652 | |
| Domain | Arm | 3.20e-06 | 31 | 140 | 5 | PF00514 | |
| Domain | ARM_REPEAT | 1.17e-05 | 40 | 140 | 5 | PS50176 | |
| Domain | ARM | 1.17e-05 | 40 | 140 | 5 | SM00185 | |
| Domain | Armadillo | 2.62e-05 | 47 | 140 | 5 | IPR000225 | |
| Domain | ARM-like | KPNA4 KPNA5 KPNA6 HEATR5A HUWE1 IQCB1 TARBP1 MED12 KPNA2 KPNA3 | 3.72e-05 | 270 | 140 | 10 | IPR011989 |
| Domain | Transform_prot_C-ets | 5.58e-05 | 2 | 140 | 2 | IPR016311 | |
| Domain | NLGN4 | 5.58e-05 | 2 | 140 | 2 | IPR030025 | |
| Domain | DUF4599 | 8.63e-05 | 12 | 140 | 3 | PF15371 | |
| Domain | DUF4599 | 8.63e-05 | 12 | 140 | 3 | IPR027970 | |
| Domain | CREPT | 1.67e-04 | 3 | 140 | 2 | IPR032337 | |
| Domain | CREPT | 1.67e-04 | 3 | 140 | 2 | PF16566 | |
| Domain | Nlgn | 5.50e-04 | 5 | 140 | 2 | IPR000460 | |
| Domain | ARM-type_fold | 1.05e-03 | 339 | 140 | 9 | IPR016024 | |
| Domain | RNA_pol_II-bd | 1.14e-03 | 7 | 140 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.14e-03 | 7 | 140 | 2 | PF04818 | |
| Domain | SIX1_SD | 1.14e-03 | 7 | 140 | 2 | IPR031701 | |
| Domain | SIX1_SD | 1.14e-03 | 7 | 140 | 2 | PF16878 | |
| Domain | Spectrin_repeat | 1.31e-03 | 29 | 140 | 3 | IPR002017 | |
| Domain | - | 1.44e-03 | 222 | 140 | 7 | 1.25.10.10 | |
| Domain | ERAP1-like_C_dom | 1.52e-03 | 8 | 140 | 2 | IPR024571 | |
| Domain | RPR | 1.52e-03 | 8 | 140 | 2 | SM00582 | |
| Domain | CID_dom | 1.52e-03 | 8 | 140 | 2 | IPR006569 | |
| Domain | ERAP1_C | 1.52e-03 | 8 | 140 | 2 | PF11838 | |
| Domain | CID | 1.52e-03 | 8 | 140 | 2 | PS51391 | |
| Domain | LRRCT | 1.74e-03 | 32 | 140 | 3 | PF01463 | |
| Domain | SPEC | 1.74e-03 | 32 | 140 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.74e-03 | 32 | 140 | 3 | IPR018159 | |
| Domain | GPS | 2.08e-03 | 34 | 140 | 3 | SM00303 | |
| Domain | PAS | 2.08e-03 | 34 | 140 | 3 | PS50112 | |
| Domain | PAS | 2.08e-03 | 34 | 140 | 3 | IPR000014 | |
| Domain | GPS | 2.26e-03 | 35 | 140 | 3 | PF01825 | |
| Domain | GPS | 2.46e-03 | 36 | 140 | 3 | PS50221 | |
| Domain | GPS | 2.66e-03 | 37 | 140 | 3 | IPR000203 | |
| Domain | PNT | 2.94e-03 | 11 | 140 | 2 | PS51433 | |
| Domain | SAM_PNT | 2.94e-03 | 11 | 140 | 2 | PF02198 | |
| Domain | Pointed_dom | 2.94e-03 | 11 | 140 | 2 | IPR003118 | |
| Domain | SAM_PNT | 2.94e-03 | 11 | 140 | 2 | SM00251 | |
| Domain | Peptidase_M1 | 3.51e-03 | 12 | 140 | 2 | IPR001930 | |
| Domain | Carboxylesterase_B_CS | 4.12e-03 | 13 | 140 | 2 | IPR019819 | |
| Domain | Peptidase_M1_N | 4.12e-03 | 13 | 140 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 4.12e-03 | 13 | 140 | 2 | PF01433 | |
| Domain | Cys-rich_flank_reg_C | 4.70e-03 | 90 | 140 | 4 | IPR000483 | |
| Domain | LRRCT | 4.70e-03 | 90 | 140 | 4 | SM00082 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.79e-03 | 14 | 140 | 2 | PS00941 | |
| Domain | Dynein_heavy_dom-2 | 4.79e-03 | 14 | 140 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.79e-03 | 14 | 140 | 2 | PF08393 | |
| Domain | COesterase | 4.79e-03 | 14 | 140 | 2 | PF00135 | |
| Domain | CarbesteraseB | 4.79e-03 | 14 | 140 | 2 | IPR002018 | |
| Domain | DHC_fam | 5.49e-03 | 15 | 140 | 2 | IPR026983 | |
| Domain | Galectin_CRD | 5.49e-03 | 15 | 140 | 2 | IPR001079 | |
| Domain | Dynein_heavy | 5.49e-03 | 15 | 140 | 2 | PF03028 | |
| Domain | Znf_GATA | 5.49e-03 | 15 | 140 | 2 | IPR000679 | |
| Domain | Gal-bind_lectin | 5.49e-03 | 15 | 140 | 2 | PF00337 | |
| Domain | GATA | 5.49e-03 | 15 | 140 | 2 | PF00320 | |
| Domain | Gal-bind_lectin | 5.49e-03 | 15 | 140 | 2 | SM00908 | |
| Domain | Dynein_heavy_dom | 5.49e-03 | 15 | 140 | 2 | IPR004273 | |
| Domain | GALECTIN | 5.49e-03 | 15 | 140 | 2 | PS51304 | |
| Domain | GLECT | 5.49e-03 | 15 | 140 | 2 | SM00276 | |
| Domain | - | 5.69e-03 | 95 | 140 | 4 | 2.60.120.200 | |
| Domain | CUB | 5.90e-03 | 49 | 140 | 3 | PF00431 | |
| Domain | 7tm_2 | 6.25e-03 | 50 | 140 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.25e-03 | 50 | 140 | 3 | PS00650 | |
| Domain | CUB | 6.25e-03 | 50 | 140 | 3 | SM00042 | |
| Domain | GATA_ZN_FINGER_1 | 6.25e-03 | 16 | 140 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 6.25e-03 | 16 | 140 | 2 | PS50114 | |
| Domain | - | 6.97e-03 | 52 | 140 | 3 | 2.60.120.290 | |
| Domain | CUB | 7.35e-03 | 53 | 140 | 3 | PS01180 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.82e-12 | 5 | 158 | 5 | 12629516 | |
| Pubmed | Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. | 1.09e-11 | 6 | 158 | 5 | 8551560 | |
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 2064827 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 9548947 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 9557700 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 9603322 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 9593140 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 7585960 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 8041786 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 8041734 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 9303297 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 11904219 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 9918876 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 7859280 | ||
| Pubmed | Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. | 1.09e-11 | 6 | 158 | 5 | 8529100 | |
| Pubmed | Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. | 1.09e-11 | 6 | 158 | 5 | 9008157 | |
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 15037073 | ||
| Pubmed | 1.09e-11 | 6 | 158 | 5 | 8876228 | ||
| Pubmed | Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. | 1.09e-11 | 6 | 158 | 5 | 7745752 | |
| Pubmed | Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. | 1.09e-11 | 6 | 158 | 5 | 8659115 | |
| Pubmed | An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A. | 1.01e-10 | 8 | 158 | 5 | 20818336 | |
| Pubmed | 1.01e-10 | 8 | 158 | 5 | 8552640 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 10525473 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 11389849 | ||
| Pubmed | Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. | 2.25e-10 | 9 | 158 | 5 | 9463369 | |
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 12414950 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 10366569 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 9366553 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 10860744 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 12368302 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 11035935 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 9275210 | ||
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 10888652 | ||
| Pubmed | Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. | 2.25e-10 | 9 | 158 | 5 | 1631159 | |
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 8105392 | ||
| Pubmed | Characterization of the nuclear import pathway for HIV-1 integrase. | 2.25e-10 | 9 | 158 | 5 | 11278458 | |
| Pubmed | 4.10e-10 | 4 | 158 | 4 | 9395085 | ||
| Pubmed | HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase. | 4.49e-10 | 10 | 158 | 5 | 9282826 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 5.01e-10 | 94 | 158 | 9 | 21542922 |
| Pubmed | HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr. | 8.21e-10 | 11 | 158 | 5 | 9562972 | |
| Pubmed | 1.40e-09 | 12 | 158 | 5 | 7494303 | ||
| Pubmed | 1.40e-09 | 12 | 158 | 5 | 14557543 | ||
| Pubmed | 2.04e-09 | 5 | 158 | 4 | 19961612 | ||
| Pubmed | Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. | 2.04e-09 | 5 | 158 | 4 | 17981117 | |
| Pubmed | 2.04e-09 | 5 | 158 | 4 | 9369227 | ||
| Pubmed | 5.26e-09 | 15 | 158 | 5 | 10964507 | ||
| Pubmed | 6.11e-09 | 6 | 158 | 4 | 10026238 | ||
| Pubmed | 1.42e-08 | 7 | 158 | 4 | 10523667 | ||
| Pubmed | Active nuclear import and cytoplasmic retention of activation-induced deaminase. | 1.42e-08 | 7 | 158 | 4 | 19412186 | |
| Pubmed | 1.48e-08 | 18 | 158 | 5 | 18664271 | ||
| Pubmed | KPNA4 FN1 KALRN PPFIBP1 SYNE1 ETS2 GATM TTC27 KPNA6 SMG5 HUWE1 RAD54L2 FRMD4B RPRD1A ATRNL1 ROBO1 CIPC ALAD HERC2 TARBP1 SNTA1 PCM1 KPNA3 | 2.12e-08 | 1285 | 158 | 23 | 35914814 | |
| Pubmed | Importin α7 is essential for zygotic genome activation and early mouse development. | 2.83e-08 | 8 | 158 | 4 | 21479251 | |
| Pubmed | Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm. | 2.83e-08 | 8 | 158 | 4 | 20015032 | |
| Pubmed | Changing expression and subcellular distribution of karyopherins during murine oogenesis. | 5.08e-08 | 9 | 158 | 4 | 26399853 | |
| Pubmed | 5.08e-08 | 9 | 158 | 4 | 21326825 | ||
| Pubmed | 8.43e-08 | 10 | 158 | 4 | 35021089 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 8871649 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 10516026 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 10212281 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KPNA4 SP1 ERBB4 SPATA31E1 PEX14 RAD54L2 ASAP2 USF3 SLC12A2 NOTCH1 RIC1 KPNA2 KPNA3 | 9.63e-08 | 430 | 158 | 13 | 35044719 |
| Pubmed | 1.32e-07 | 11 | 158 | 4 | 22509482 | ||
| Pubmed | 2.84e-07 | 13 | 158 | 4 | 34950606 | ||
| Pubmed | Importin α3 regulates chronic pain pathways in peripheral sensory neurons. | 3.67e-07 | 4 | 158 | 3 | 32792398 | |
| Pubmed | MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. | 3.67e-07 | 4 | 158 | 3 | 29370303 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 30396568 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 24103892 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.67e-07 | 4 | 158 | 3 | 10469592 | |
| Pubmed | Molecular determinants for nuclear import of influenza A PB2 by importin α isoforms 3 and 7. | 3.67e-07 | 4 | 158 | 3 | 25599645 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17306895 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 28240251 | ||
| Pubmed | 3.96e-07 | 14 | 158 | 4 | 17411366 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PPFIBP1 SYNE1 URB2 TBL1XR1 FANCA SLC38A10 SLC12A2 PRCP LPCAT3 ITSN2 TMF1 ROBO1 ALCAM HERC2 TARBP1 | 1.12e-06 | 719 | 158 | 15 | 35337019 |
| Pubmed | 1.52e-06 | 43 | 158 | 5 | 1249422 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 26491019 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 20701745 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 15063128 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | KPNA4 KPNA5 PPFIBP1 UGGT1 TTC27 PEX14 KPNA6 URB2 COMMD9 HERC2 RFT1 PCM1 MOCOS KPNA2 KPNA3 | 2.01e-06 | 754 | 158 | 15 | 33060197 |
| Pubmed | 2.39e-06 | 47 | 158 | 5 | 814163 | ||
| Pubmed | 2.66e-06 | 48 | 158 | 5 | 11955599 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 2.95e-06 | 49 | 158 | 5 | 8951372 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 15788656 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 18187047 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 26052702 | ||
| Pubmed | KPNA4 UGGT1 TTC27 RNF213 KPNA6 HUWE1 PTPN5 SLC12A2 PTPRH TMF1 ROBO1 CRYBG3 HERC2 SIX2 NOTCH1 KPNA2 KPNA3 | 6.34e-06 | 1049 | 158 | 17 | 27880917 | |
| Pubmed | 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). | 7.57e-06 | 9 | 158 | 3 | 15057270 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 26269593 | ||
| Pubmed | Cellular cofactors of lentiviral integrase: from target validation to drug discovery. | 7.57e-06 | 9 | 158 | 3 | 22928108 | |
| Pubmed | 1.08e-05 | 10 | 158 | 3 | 12970426 | ||
| Pubmed | 1.08e-05 | 10 | 158 | 3 | 15689618 | ||
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | 1.10e-05 | 109 | 158 | 6 | 9074928 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 14759373 | ||
| Pubmed | Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. | 2.05e-05 | 2 | 158 | 2 | 17986575 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33281191 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19305494 | ||
| Pubmed | ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. | 2.05e-05 | 2 | 158 | 2 | 18958307 | |
| Pubmed | Ets-1 and Ets-2 protooncogene expression in theca cells of the adult mouse ovary. | 2.05e-05 | 2 | 158 | 2 | 1511734 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23183221 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24855039 | ||
| Pubmed | Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. | 2.05e-05 | 2 | 158 | 2 | 25243787 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32623935 | ||
| Interaction | PPP4R1L interactions | 1.82e-07 | 87 | 142 | 8 | int:PPP4R1L | |
| Interaction | BRCA1 interactions | DNHD1 NCOA3 SP1 BRIP1 RBBP5 UGGT1 GATA3 ETS1 ETS2 KPNA6 ZMIZ1 HUWE1 RAD54L2 CUBN TBL1XR1 SPAG5 RPRD1B FANCA RPRD1A BRCA2 HERC2 USH2A MED12 KPNA2 KPNA3 | 1.99e-06 | 1249 | 142 | 25 | int:BRCA1 |
| Interaction | HDAC1 interactions | KPNA4 SP1 GATAD2A FN1 RBBP5 GATA3 ETS1 TTC27 PEX14 KPNA6 ZMIZ1 TBL1XR1 SPAG5 USP38 BRCA2 TMF1 CRYBG3 MED12 NOTCH1 PCM1 KPNA2 KPNA3 | 1.01e-05 | 1108 | 142 | 22 | int:HDAC1 |
| Interaction | ETS1 interactions | 2.40e-05 | 121 | 142 | 7 | int:ETS1 | |
| Interaction | EPAS1 interactions | 3.17e-05 | 173 | 142 | 8 | int:EPAS1 | |
| Interaction | FBXO2 interactions | FN1 ADGRV1 ERVMER34-1 HPSE LRIG2 LIPA PRCP IQCB1 ROBO1 ALCAM ADGRF1 NOTCH1 | 3.53e-05 | 411 | 142 | 12 | int:FBXO2 |
| Cytoband | 22q11.2 | 3.85e-06 | 120 | 157 | 6 | 22q11.2 | |
| Cytoband | 10p15 | 2.41e-04 | 7 | 157 | 2 | 10p15 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.42e-08 | 18 | 98 | 5 | 596 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.45e-06 | 43 | 98 | 5 | 409 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 8.78e-06 | 89 | 98 | 6 | 353 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.65e-04 | 20 | 98 | 3 | 548 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 1.73e-04 | 4 | 98 | 2 | 1244 | |
| GeneFamily | SINE class homeoboxes | 4.30e-04 | 6 | 98 | 2 | 525 | |
| GeneFamily | Fibronectin type III domain containing | 1.79e-03 | 160 | 98 | 5 | 555 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.92e-03 | 15 | 98 | 2 | 82 | |
| GeneFamily | Galectins | 2.92e-03 | 15 | 98 | 2 | 629 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP | 1.55e-05 | 200 | 144 | 8 | M9591 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 1.55e-05 | 200 | 144 | 8 | M8208 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_DN | 1.60e-05 | 145 | 144 | 7 | M0 | |
| Coexpression | MATHEW_FANCONI_ANEMIA_GENES | 2.59e-05 | 11 | 144 | 3 | M12972 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.54e-09 | 200 | 149 | 10 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.58e-08 | 200 | 149 | 9 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.58e-08 | 200 | 149 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.58e-08 | 200 | 149 | 9 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-08 | 162 | 149 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | NCOA3 IGLV2-23 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 CD180 SDC1 | 3.44e-07 | 197 | 149 | 8 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-07 | 145 | 149 | 7 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.77e-07 | 156 | 149 | 7 | 5d9e1df70f2e9219f6b029be2e39297605d36726 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 166 | 149 | 7 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-06 | 172 | 149 | 7 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-06 | 172 | 149 | 7 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 2.19e-06 | 176 | 149 | 7 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 2.19e-06 | 176 | 149 | 7 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.19e-06 | 176 | 149 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.27e-06 | 177 | 149 | 7 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.27e-06 | 177 | 149 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.27e-06 | 177 | 149 | 7 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.27e-06 | 177 | 149 | 7 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-06 | 178 | 149 | 7 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-06 | 179 | 149 | 7 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-06 | 179 | 149 | 7 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-06 | 179 | 149 | 7 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 2.73e-06 | 182 | 149 | 7 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.83e-06 | 183 | 149 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.93e-06 | 184 | 149 | 7 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.93e-06 | 184 | 149 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 185 | 149 | 7 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 3.04e-06 | 185 | 149 | 7 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.15e-06 | 186 | 149 | 7 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 187 | 149 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 187 | 149 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 188 | 149 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-06 | 189 | 149 | 7 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-06 | 189 | 149 | 7 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-06 | 191 | 149 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.89e-06 | 192 | 149 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.89e-06 | 192 | 149 | 7 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-06 | 194 | 149 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-06 | 195 | 149 | 7 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-06 | 195 | 149 | 7 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 196 | 149 | 7 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 4.45e-06 | 196 | 149 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 197 | 149 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 198 | 149 | 7 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-B_naive|Leuk-UTI / Disease, condition lineage and cell class | 4.92e-06 | 199 | 149 | 7 | f93efc7d4c4a40d65fa10b53a2da6d961930f7d2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-2|TCGA-Uvea / Sample_Type by Project: Shred V9 | 6.58e-06 | 136 | 149 | 6 | b460669c13ed43ff3885acd38ce18f75d693738d | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-06 | 145 | 149 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.24e-05 | 152 | 149 | 6 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 154 | 149 | 6 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.55e-05 | 158 | 149 | 6 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.55e-05 | 158 | 149 | 6 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.55e-05 | 158 | 149 | 6 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-05 | 159 | 149 | 6 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.60e-05 | 159 | 149 | 6 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 159 | 149 | 6 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-05 | 159 | 149 | 6 | 1827493fb464bbddb2ee23f99472cfbcaf57405b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 161 | 149 | 6 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-05 | 162 | 149 | 6 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-05 | 162 | 149 | 6 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.78e-05 | 162 | 149 | 6 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 165 | 149 | 6 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.98e-05 | 165 | 149 | 6 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.05e-05 | 166 | 149 | 6 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 2.19e-05 | 168 | 149 | 6 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.19e-05 | 168 | 149 | 6 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 169 | 149 | 6 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.26e-05 | 169 | 149 | 6 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 170 | 149 | 6 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 170 | 149 | 6 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 171 | 149 | 6 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 171 | 149 | 6 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 2.50e-05 | 172 | 149 | 6 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-05 | 174 | 149 | 6 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 174 | 149 | 6 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 176 | 149 | 6 | cb21342dd135cc80a50aafe7bf8bf31265db68dd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-05 | 176 | 149 | 6 | 67d6dc38708692f8c58cea5ed896f10718e9ffa6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.84e-05 | 176 | 149 | 6 | 125be81311f87563ca321472fcce6e0e0ae24c16 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.94e-05 | 177 | 149 | 6 | 0f2616a81f8fbede77c860b2126e3fa826672da3 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 177 | 149 | 6 | b860013f1fd397400a62d66ab521cfc81349ffe2 | |
| ToppCell | Control-Lymphocyte-B-B_naive|Control / Disease, Lineage and Cell Type | 3.13e-05 | 179 | 149 | 6 | 35994281904bfe38766e715ab608211a5ca865a9 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 3.13e-05 | 179 | 149 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.22e-05 | 180 | 149 | 6 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 180 | 149 | 6 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_naive|Leuk-UTI / Disease, Lineage and Cell Type | 3.33e-05 | 181 | 149 | 6 | fb0b5a94796b99c64091f9890f7a09c39bbc3f73 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.43e-05 | 182 | 149 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 3.54e-05 | 183 | 149 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 3.54e-05 | 183 | 149 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 184 | 149 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 184 | 149 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-05 | 184 | 149 | 6 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-05 | 184 | 149 | 6 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| Drug | Hcda | 1.02e-07 | 8 | 143 | 4 | CID005312573 | |
| Drug | Tat11 | 1.83e-07 | 9 | 143 | 4 | CID000480142 | |
| Drug | HYCRON linker | 2.40e-06 | 5 | 143 | 3 | CID011069636 | |
| Drug | CNI-H0294 | 2.40e-06 | 5 | 143 | 3 | CID000073088 | |
| Drug | AC1LA3FM | 4.79e-06 | 6 | 143 | 3 | CID000480797 | |
| Drug | dmDBP | 4.79e-06 | 6 | 143 | 3 | CID005316801 | |
| Drug | Lysylproline | 1.26e-05 | 48 | 143 | 5 | CID000171204 | |
| Disease | Malignant neoplasm of breast | KPNA5 NCOA3 ERBB4 BRIP1 FN1 KALRN SYNE1 GATA3 ETS2 ZMIZ1 CUBN HPSE BMPR2 RPRD1A BRCA2 ITSN2 ROBO1 HERC2 ENPEP MED12 NOTCH1 DOP1A | 5.09e-09 | 1074 | 137 | 22 | C0006142 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.53e-08 | 41 | 137 | 6 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.53e-08 | 41 | 137 | 6 | C0858252 | |
| Disease | Breast Carcinoma | NCOA3 ERBB4 BRIP1 FN1 SYNE1 GATA3 ETS2 HPSE BMPR2 BRCA2 ITSN2 HERC2 MED12 NOTCH1 | 2.31e-07 | 538 | 137 | 14 | C0678222 |
| Disease | Pancytopenia | 6.14e-06 | 26 | 137 | 4 | C0030312 | |
| Disease | uric acid measurement | CDC42BPG SHLD2 ERBB4 TTC27 ADGRV1 ZMIZ1 CUBN F5 FANCA BMPR2 ASAP2 RFT1 | 2.91e-05 | 610 | 137 | 12 | EFO_0004761 |
| Disease | Fanconi anemia | 3.43e-05 | 14 | 137 | 3 | cv:C0015625 | |
| Disease | Mammary Carcinoma, Human | NCOA3 BRIP1 FN1 SYNE1 ETS2 HPSE BMPR2 BRCA2 ITSN2 MED12 NOTCH1 | 3.59e-05 | 525 | 137 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | NCOA3 BRIP1 FN1 SYNE1 ETS2 HPSE BMPR2 BRCA2 ITSN2 MED12 NOTCH1 | 3.59e-05 | 525 | 137 | 11 | C1257931 |
| Disease | Mammary Neoplasms | NCOA3 BRIP1 FN1 SYNE1 ETS2 HPSE BMPR2 BRCA2 ITSN2 MED12 NOTCH1 | 3.72e-05 | 527 | 137 | 11 | C1458155 |
| Disease | respiratory system disease | 6.15e-05 | 145 | 137 | 6 | EFO_0000684 | |
| Disease | Bone marrow hypocellularity | 7.59e-05 | 18 | 137 | 3 | C1855710 | |
| Disease | urate measurement, bone density | ERBB4 PPFIBP1 SYNE1 ETS1 ETS2 PEX14 MARCHF7 FANCA ADGRE4P ROBO1 USH2A | 1.55e-04 | 619 | 137 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Fanconi Anemia | 2.09e-04 | 25 | 137 | 3 | C0015625 | |
| Disease | tri-iodothyronine/thyroxine ratio measurement | 2.12e-04 | 5 | 137 | 2 | EFO_0009779 | |
| Disease | urate measurement | CDC42BPG SHLD2 ERBB4 ADGRV1 ZMIZ1 CUBN FRMD4B BMPR2 ASAP2 USP38 TMF1 RFT1 CLNK | 2.83e-04 | 895 | 137 | 13 | EFO_0004531 |
| Disease | Varicose veins | 2.93e-04 | 193 | 137 | 6 | HP_0002619 | |
| Disease | renal overload-type gout | 3.17e-04 | 6 | 137 | 2 | EFO_0021525 | |
| Disease | Adult only | 3.17e-04 | 6 | 137 | 2 | C3842001 | |
| Disease | Miller Dieker syndrome | 3.27e-04 | 29 | 137 | 3 | C0265219 | |
| Disease | Bilateral Wilms Tumor | 3.27e-04 | 29 | 137 | 3 | C2930471 | |
| Disease | skin pigmentation measurement | 4.59e-04 | 137 | 137 | 5 | EFO_0007009 | |
| Disease | Abnormality of radial ray | 4.82e-04 | 33 | 137 | 3 | C4228778 | |
| Disease | obsolete_red blood cell distribution width | ASNSD1 SP1 BRIP1 GATAD2A KALRN RBBP5 SLC6A19 SMG5 TBL1XR1 BMPR2 LIPA SLC12A2 PTPRH LPCAT3 MUC4 NOTCH1 | 5.32e-04 | 1347 | 137 | 16 | EFO_0005192 |
| Disease | Animal Mammary Neoplasms | 5.40e-04 | 142 | 137 | 5 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 5.40e-04 | 142 | 137 | 5 | C1257925 | |
| Disease | eosinophil cationic protein measurement | 5.88e-04 | 8 | 137 | 2 | EFO_0010913 | |
| Disease | cervical cancer (is_marker_for) | 6.25e-04 | 36 | 137 | 3 | DOID:4362 (is_marker_for) | |
| Disease | Nephroblastoma | 6.25e-04 | 36 | 137 | 3 | C0027708 | |
| Disease | Prostatic Neoplasms | NCOA3 TBL1XR1 SLC12A2 BRCA2 ITSN2 TMF1 ROBO1 ALAD MUC4 MED12 | 6.26e-04 | 616 | 137 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 TBL1XR1 SLC12A2 BRCA2 ITSN2 TMF1 ROBO1 ALAD MUC4 MED12 | 6.26e-04 | 616 | 137 | 10 | C0376358 |
| Disease | mean corpuscular hemoglobin concentration | SP1 BRIP1 PRR5L GATAD2A KALRN TRIM54 SMG5 URB2 TBL1XR1 FRMD4B DMXL1 BMPR2 RPRD1A INTS13 | 6.46e-04 | 1105 | 137 | 14 | EFO_0004528 |
| Disease | longitudinal alcohol consumption measurement | 7.54e-04 | 9 | 137 | 2 | EFO_0007645 | |
| Disease | Mammary Neoplasms, Experimental | 8.02e-04 | 155 | 137 | 5 | C0024668 | |
| Disease | Fanconi anemia (is_implicated_in) | 9.40e-04 | 10 | 137 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Major Depressive Disorder | 9.82e-04 | 243 | 137 | 6 | C1269683 | |
| Disease | Carcinomatosis | 1.01e-03 | 163 | 137 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.01e-03 | 163 | 137 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.01e-03 | 163 | 137 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.01e-03 | 163 | 137 | 5 | C0205696 | |
| Disease | Carcinoma | 1.03e-03 | 164 | 137 | 5 | C0007097 | |
| Disease | Adenocarcinoma of large intestine | 1.06e-03 | 96 | 137 | 4 | C1319315 | |
| Disease | melanoma | 1.09e-03 | 248 | 137 | 6 | C0025202 | |
| Disease | hip geometry | 1.13e-03 | 44 | 137 | 3 | EFO_0004685 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.15e-03 | 11 | 137 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Congenital Abnormality | 1.15e-03 | 11 | 137 | 2 | C0000768 | |
| Disease | hearing impairment | 1.15e-03 | 98 | 137 | 4 | C1384666 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.20e-03 | 45 | 137 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Vitiligo | 1.28e-03 | 101 | 137 | 4 | EFO_0004208 | |
| Disease | myocardial infarction | 1.28e-03 | 350 | 137 | 7 | EFO_0000612 | |
| Disease | Unipolar Depression | 1.36e-03 | 259 | 137 | 6 | C0041696 | |
| Disease | hair colour measurement, hair morphology measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 1.45e-03 | 48 | 137 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | bipolar disorder | 1.54e-03 | 577 | 137 | 9 | MONDO_0004985 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 1.61e-03 | 13 | 137 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | Colorectal Carcinoma | 1.67e-03 | 702 | 137 | 10 | C0009402 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.87e-03 | 713 | 137 | 10 | EFO_0005689 | |
| Disease | skin melanoma (is_implicated_in) | 1.88e-03 | 14 | 137 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | nephroblastoma (is_implicated_in) | 1.88e-03 | 14 | 137 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | trimethylamine-N-oxide measurement | 1.88e-03 | 14 | 137 | 2 | EFO_0010541 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.88e-03 | 14 | 137 | 2 | C0677776 | |
| Disease | leukemia | 2.15e-03 | 55 | 137 | 3 | C0023418 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.16e-03 | 15 | 137 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.16e-03 | 15 | 137 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.16e-03 | 15 | 137 | 2 | C0154091 | |
| Disease | gout | 2.26e-03 | 196 | 137 | 5 | EFO_0004274 | |
| Disease | hippocampal atrophy | 2.27e-03 | 56 | 137 | 3 | EFO_0005039 | |
| Disease | amygdala volume change measurement | 2.46e-03 | 16 | 137 | 2 | EFO_0021490 | |
| Disease | response to methotrexate | 2.46e-03 | 16 | 137 | 2 | GO_0031427 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.46e-03 | 16 | 137 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.46e-03 | 16 | 137 | 2 | C2713443 | |
| Disease | colorectal cancer (is_implicated_in) | 2.48e-03 | 121 | 137 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Malignant neoplasm of skin | 2.63e-03 | 59 | 137 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.63e-03 | 59 | 137 | 3 | C0037286 | |
| Disease | pursuit maintenance gain measurement | 2.64e-03 | 123 | 137 | 4 | EFO_0008433 | |
| Disease | Adenomatous Polyposis Coli | 2.78e-03 | 17 | 137 | 2 | C0032580 | |
| Disease | celiac disease | 2.87e-03 | 126 | 137 | 4 | EFO_0001060 | |
| Disease | breast carcinoma | ERBB4 GATAD2A PEX14 ZMIZ1 UBE2U KCNU1 SLC12A2 BRCA2 TLR1 ALCAM CD180 PCM1 | 2.89e-03 | 1019 | 137 | 12 | EFO_0000305 |
| Disease | acute kidney failure (biomarker_via_orthology) | 2.89e-03 | 61 | 137 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | Carcinoma of bladder | 3.12e-03 | 18 | 137 | 2 | C0699885 | |
| Disease | bone mineral content measurement | 3.22e-03 | 130 | 137 | 4 | EFO_0007621 | |
| Disease | skin sensitivity to sun | 3.47e-03 | 19 | 137 | 2 | EFO_0004795 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 3.47e-03 | 19 | 137 | 2 | EFO_0000220, GO_0097327 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.78e-03 | 67 | 137 | 3 | C3463824 | |
| Disease | diet measurement, body mass index | 3.85e-03 | 20 | 137 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | serum homoarginine measurement | 3.85e-03 | 20 | 137 | 2 | EFO_0005421 | |
| Disease | Adenocarcinoma of prostate | 3.85e-03 | 20 | 137 | 2 | C0007112 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 3.88e-03 | 137 | 137 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | skin pigmentation | 4.10e-03 | 69 | 137 | 3 | EFO_0003784 | |
| Disease | haptoglobin measurement | 4.24e-03 | 21 | 137 | 2 | EFO_0004640 | |
| Disease | BREAST CANCER | 4.24e-03 | 21 | 137 | 2 | 114480 | |
| Disease | Malignant Glioma | 4.27e-03 | 70 | 137 | 3 | C0555198 | |
| Disease | mixed gliomas | 4.27e-03 | 70 | 137 | 3 | C0259783 | |
| Disease | Abnormality of refraction | 4.28e-03 | 673 | 137 | 9 | HP_0000539 | |
| Disease | Malignant neoplasm of urinary bladder | 4.30e-03 | 141 | 137 | 4 | C0005684 | |
| Disease | estrogen-receptor negative breast cancer | 4.44e-03 | 71 | 137 | 3 | EFO_1000650 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQASTLISDWISSNR | 831 | Q9UKU6 | |
| TWTQAGQGQLRQVLS | 216 | Q14146 | |
| TINWTTLFSTINQRI | 471 | Q15303 | |
| SNFSTNVSLERNWTG | 1016 | Q4VNC0 | |
| NSTRLWNSQSSIDQK | 396 | O42043 | |
| KNSTRLWNSQSSIDQ | 506 | O71037 | |
| KNSTRLWNSQSSIDQ | 506 | Q902F8 | |
| NSTRLWNSQSSIDQK | 506 | Q9UKH3 | |
| GSQTSFQWTQEQPLS | 226 | Q8IYX3 | |
| IASSNNLLNKNAWGS | 326 | Q68DQ2 | |
| SIADNILNSASVTNW | 376 | Q5T601 | |
| QSRLQNGSSGWSITT | 371 | P07510 | |
| NNSQGTTQSNVDIWV | 106 | Q86SQ3 | |
| HGNVSANWVLTRNST | 426 | Q8WXG9 | |
| NSGTLGNVTVQWVAT | 2261 | Q8WXG9 | |
| GSTSSVGQAWLNQVL | 971 | Q5JWR5 | |
| GRWSQVTLTQVLQTQ | 4286 | Q96M86 | |
| QSLTSIPAFSQRNWQ | 996 | Q9Y4B4 | |
| GLQNSTTQSLWLGTF | 241 | Q99467 | |
| LTGSSYLQLWSNTNL | 126 | Q9Y485 | |
| SQISRQLNQSQVAWT | 561 | Q9HBZ2 | |
| LTNSNRLTTTRNAVW | 221 | O15131 | |
| WTVSNITAGNRAQIQ | 361 | O15131 | |
| LSGGTQRDWSQTLNL | 71 | Q96AA3 | |
| TVWNRASQSRQSGLI | 221 | P49796 | |
| DAGISNIQRSQSWLS | 1161 | Q4ADV7 | |
| NIQRSQSWLSNIGPT | 1166 | Q4ADV7 | |
| NLSQTQLATIWTLAD | 276 | Q9NZM3 | |
| IWSQNATNLVSSLLT | 111 | P54829 | |
| VSLLSLWSNRINTAN | 651 | Q9NVM9 | |
| VSSLSRQVTQLQGQW | 561 | Q6DT37 | |
| RDWSNGAVLQASSQL | 516 | Q86YP4 | |
| AQWTLGSNTYQAILS | 4461 | Q99102 | |
| AWALTNIASGTSQQT | 146 | O60684 | |
| TGFSNSVWLSTLTLQ | 151 | P58173 | |
| AWALTNIASGTSAQT | 136 | O00505 | |
| NLTQSRSTTWKLNNL | 241 | O00370 | |
| STSLNGQCEWLSRLQ | 2301 | P46531 | |
| KQIVSSQNGLSAWTS | 116 | Q96QH8 | |
| LTQGTGSWAQSALTQ | 11 | A0A075B6J2 | |
| LSWSDTAQVTNQRVQ | 791 | P19823 | |
| SNRLTTLSWQLFQTL | 136 | Q16288 | |
| WVQRTFQSTQAATAS | 31 | P50440 | |
| WIASGQTLLQASQQD | 671 | Q86W92 | |
| LRAWQTATTTLNASN | 16 | P13716 | |
| TVQSAAQAVLQSGWS | 881 | O95714 | |
| WLQSSIFSGGLQTSQ | 1336 | O95714 | |
| NTQINNSWGSEERSL | 281 | Q6DKI2 | |
| NVGKVQTASSANTLW | 791 | O43150 | |
| QTASSANTLWKTNSV | 796 | O43150 | |
| WWLTGSNLTLSVNNS | 281 | Q9H9K5 | |
| NTQINNSWGSEERSL | 281 | Q3B8N2 | |
| LTQDTGSWAQSALTQ | 11 | P01705 | |
| QSWSSQSSFNSLQRV | 266 | P14921 | |
| SVNSGTWIASNSELT | 1446 | Q15154 | |
| SSWDSVIQNKTGRNQ | 41 | P22794 | |
| SLLQSWNSQSSLLDV | 291 | P15036 | |
| ISNRQSFWQSAGETN | 346 | Q32MH5 | |
| GSQIWQQSVASTLDT | 2611 | O60229 | |
| LQNVQTIPSWLSGTS | 361 | Q6ZR08 | |
| WDAINRLSNTGSGLQ | 241 | P42785 | |
| TGTIASFNINTNAWV | 331 | Q6P1A2 | |
| QQNGTASSRKTLWNQ | 306 | Q92917 | |
| LTQGTGSWAQSALTQ | 11 | A0A075B6J9 | |
| NFWLVTARSQSAINT | 101 | Q93074 | |
| LTGSRVWNNSSTVNA | 536 | Q96EN8 | |
| AWNQSRTNSIISSQI | 1106 | A8MYU2 | |
| LNNASSLFEQWLNGT | 761 | Q07075 | |
| ITSWVSGSINSLVQT | 146 | O95006 | |
| SASWLSGLTNSVAQT | 146 | Q8NGU4 | |
| SVNQWGSQLGLSVLS | 921 | Q7Z6Z7 | |
| SAAVAIWQTLQQTTG | 101 | Q96PC2 | |
| IWQTLQQTTGSNGSD | 106 | Q96PC2 | |
| KNSTRLWNSQSSIDQ | 1266 | P63135 | |
| LLRTADLQWNSSNAQ | 191 | Q9Y251 | |
| ASISSGVVSIWAQNQ | 311 | Q15291 | |
| ITQLGLQNSTITFWN | 96 | P41217 | |
| ARQALQLSSSSAWNS | 41 | Q6MZQ0 | |
| QLSSSSAWNSVQTAV | 46 | Q6MZQ0 | |
| QTKRVSWSSFNSLGQ | 996 | Q9BX63 | |
| AWALTNIASGTSEQT | 141 | P52292 | |
| AIIQSGTALSSWAVN | 276 | Q8NFZ3 | |
| VSTWRTEAQANQISL | 106 | Q9P000 | |
| WTLSNPNQGNSSISI | 2601 | O60494 | |
| QTTTTTLWRRNANGD | 321 | P23771 | |
| VSSTNASGNWRTQLT | 951 | Q9Y2L6 | |
| TQTILLSNRTNQTWN | 4646 | Q4G0P3 | |
| QNSRLSAQRTQAGWL | 541 | Q86XA9 | |
| WNSSITLTSQAGAVF | 211 | O00115 | |
| NLIDNGSWPATTTQN | 556 | P51587 | |
| NSTRLWNSQSSIDQK | 396 | P61566 | |
| KNSTRLWNSQSSIDQ | 506 | P61570 | |
| KNSTRLWNSQSSIDQ | 506 | Q69384 | |
| NSTRLWNSQSSIDQK | 396 | P61567 | |
| STGQEALSQTTISWA | 2201 | P02751 | |
| LQALTSGWSVAASLQ | 1056 | O15360 | |
| QQSDTWSLSKTSLVN | 921 | Q8NCU4 | |
| TSSELNSGQNFLTQW | 6 | Q9HC77 | |
| TSSQLSTPLQQWRQG | 66 | P01880 | |
| WTILLVSTAAASQNQ | 16 | Q13873 | |
| SNNFNLNITWSVGST | 1151 | Q5VV63 | |
| NSTRLWNSQSSIDQK | 506 | P61565 | |
| NTISQSPGWAQTQLA | 196 | Q6ZN28 | |
| NVGNGLNTLSDSSWR | 106 | Q9H992 | |
| LSSVGTQTSGLANQW | 156 | Q9NWL6 | |
| SRIQGGWTTISQLTQ | 71 | Q15051 | |
| WNQQDGTLSLSQRQL | 76 | Q5UCC4 | |
| QIRASSSWQSVNESG | 266 | Q8N8Z6 | |
| NNWTGQLSYRTLATV | 36 | D6RIA3 | |
| LFDQQGSRWTLQATT | 296 | P46059 | |
| ASNWGLITNIVNSIV | 6 | Q9HBR0 | |
| QWTITGSGSVINQTE | 446 | Q13740 | |
| AIIQSGTALSSWAVN | 276 | Q8N0W4 | |
| LTQGTGSWAQSALTQ | 11 | P01706 | |
| STSWVIGFANSLLQT | 146 | P59922 | |
| SVSWLSGGINSAVQT | 176 | Q8NGS6 | |
| LTQGTGSWAQSALTQ | 11 | P01704 | |
| VLITGSLNWTTQAIQ | 166 | Q8N2A8 | |
| GWSQRGSLSQQENLL | 56 | Q9H0K4 | |
| GTSWVSNVFTNITQL | 351 | O75445 | |
| RGQVQSSSAINLSWS | 1061 | O75445 | |
| GSDSVTLTWTTLSNQ | 1161 | O75445 | |
| LNISTSISDSGSIQW | 181 | Q695T7 | |
| LSNSQQSVQTLSLWL | 16 | Q9NQG5 | |
| VQQTVSLTSTLQQDW | 631 | Q96R06 | |
| SARSWATAIQAQVNT | 256 | Q13424 | |
| LGGSNSQVSALSWSQ | 276 | B4DYI2 | |
| AQSSQSLWNRLSVLL | 676 | Q9UPR3 | |
| LAQARTTWTQQRQSS | 6216 | Q8NF91 | |
| NSSDLAGAQQITWQV | 381 | Q14DG7 | |
| TAVNNWLISPQNASR | 966 | P12259 | |
| LTQGTGSWAQSALTQ | 11 | P01709 | |
| STVNGVSWTNETQRQ | 176 | Q9Y6Q9 | |
| QWIGETVLQSTFSSQ | 516 | Q86V20 | |
| NTQSQSWNVETLRSS | 206 | Q9UHJ6 | |
| ALQDITLSQQTPSTW | 51 | P18827 | |
| TGLTTTQVSNWFKNR | 161 | Q15475 | |
| LATTVWVSRNPSSQN | 451 | Q6ZUB1 | |
| SSTLVSQQLWGLAQQ | 251 | Q9UIF7 | |
| NSQVSALSWSQETTK | 286 | P0DKV0 | |
| TATQLSQGANGWQII | 96 | P08047 | |
| ATTSTNWILESQNIN | 196 | O75381 | |
| LPIIQSNQVSSNSWG | 151 | Q96QB1 | |
| WNLSENSTSGSTQLV | 196 | Q9BZK7 | |
| LSNLTLNNIETTWNS | 246 | Q15399 | |
| TSISIGQPTWNTQTR | 116 | Q7Z7G1 | |
| KQGSSSSQLQSWTVQ | 101 | Q9C0C6 | |
| STFSILQTWDTINLN | 536 | Q63HN8 | |
| QASNPLWQSRGSTTV | 56 | Q9BYV2 | |
| SIQSSVQQGLQTQDW | 36 | C9J3V5 | |
| ENLQATLGSQTSSWE | 776 | P82094 | |
| QATSWALTSQLQQLR | 101 | A0A0J9YY54 | |
| QGLQAAGTDSSQTIW | 341 | P0CB47 | |
| LSNSQQSVQTLSLWL | 16 | Q96P16 | |
| VNWGSSTQALTYLNA | 756 | P55011 | |
| QATSWALTSQLQQLR | 101 | A0A0J9YWL9 | |
| AGNTQTTWTTLQLAG | 426 | Q68DE3 | |
| TTWTTLQLAGNTIQP | 431 | Q68DE3 | |
| DLISWTNTLNTNTSE | 306 | Q5VVX9 | |
| TVTLSWQPNLNSGAT | 576 | Q9Y6N7 | |
| ILNQSAWTSQSNSLA | 416 | Q8NB14 | |
| TGLTTTQVSNWFKNR | 161 | Q9NPC8 | |
| IISSLSNTQLIFWAN | 976 | Q13395 | |
| SWIVSASNVSQGSLS | 1046 | Q13395 | |
| NWTSLKNILSGLNAS | 16 | Q9BXT5 | |
| LGVSSLQLFVQSNWT | 96 | Q6P3X3 | |
| NAVTSLSKQDWTNST | 476 | Q9HD43 | |
| SRAIWAALQTQTSNA | 811 | Q9NYU2 | |
| VVTTVWGVTNTSQSQ | 166 | Q9ULJ6 | |
| NTNWPASVQVSVNAT | 621 | Q9ULJ6 | |
| AWALTNIASGTSEQT | 136 | O00629 | |
| WELLQQVNTSTGTNN | 196 | Q7Z794 | |
| QAQLCSSNITSDIWS | 946 | Q96L42 | |
| DSSNWVTNLANSSLG | 91 | P38571 | |
| SGKSLTQSLWLNNNV | 46 | Q96E66 | |
| RLSNWNISLESQTLQ | 86 | O94898 |